Three New York startups disclosed fresh funding rounds in SEC filings dated August 19, 2026, pulling in a combined $79.4 million. K Health, the AI-powered primary care platform, led the pack with nearly $69 million from 19 investors. Two younger AI ventures, Qualitate and Status, also filed paperwork revealing new capital.
K Health: $68.9M for AI primary care
K Health raised $68,949,885, the filing shows. The digital health company, founded in 2016 by Allon Bloch, Adam Singolda, Israel Roth, and Ran Shaul, delivers AI-powered clinical services through partnerships with major health systems. Singolda is also the CEO of content recommendation platform Taboola, an unusual dual role that has kept K Health plugged into the consumer tech ecosystem.
The round drew 19 investors. Neither the SEC filing nor the company disclosed the specific backers or the valuation. K Health's platform uses AI to analyze patient symptoms and health data, then connects users with physicians when needed. The company has positioned itself as infrastructure for health systems rather than a direct-to-consumer play, a distinction that shapes its growth path.
Qualitate brings AI to expert research
Qualitate, a much younger company, also filed funding paperwork. Founded in 2024 by Sagar Kadakia, the startup builds an "AI-native primary intelligence platform" that runs structured expert discussions at scale. Its target customers are investment and strategy teams who need rapid expert insights without scheduling dozens of calls.
The filing listed 36 investors but did not disclose the total amount raised. That investor count suggests either a crowded seed round or a party round with many smaller checks. For founders watching the expert network space, Qualitate represents a bet that AI can automate the qualitative research process that firms like GLG and AlphaSights have built into large manual businesses.
Status raises $10.5M for AI social simulation
Status, founded in 2020, filed a $10,499,998 raise from seven investors. The company describes itself as an AI-driven social simulation platform that blends social media, roleplaying, and interactive storytelling. Its five co-founders, Fai Nur, Amit Bhatnagar, Blossom Okonkwo, Great Okonkwo, and Pritesh Kadiwala, are building for a category that barely existed when they started.
Seven investors for a $10.5 million round implies larger check sizes than Qualitate's fragmented cap table, possibly institutional leads with a few angels. The social simulation space has grown alongside advances in large language models, and Status appears to be betting that AI-generated characters and storylines can hold users longer than static content.
What the filings don't reveal
SEC filings are paperwork, not press releases. They confirm capital moved but rarely include the narrative: who led, at what valuation, or how the founders plan to deploy the money. K Health's $69 million is substantial, but without knowing the valuation, it's impossible to say whether this represents a strong up round, a flat extension, or something else.
Qualitate's undisclosed amount is harder to read. Thirty-six investors could mean a heavily oversubscribed round with momentum or a messy close with many small checks. Founders parsing these signals should note the difference.
Logicity's Take
K Health's $69M round signals continued investor appetite for AI-powered healthcare infrastructure, even as the broader market has cooled. The Taboola connection gives the company unusual reach into consumer distribution channels. For founders in healthtech, the lesson is clear: partner with existing health systems rather than trying to replace them. Qualitate and Status, both AI-native plays, show that 2024-era startups are raising on the promise of AI automation in traditionally manual verticals.
Another major startup financing event this month, offering context on current market conditions
The funding landscape in August 2026
These three filings land in a market still recalibrating from the 2022-2023 correction. Healthcare AI and enterprise intelligence tools have held investor interest better than consumer plays. K Health's size and investor count suggest confidence in its model. The two smaller rounds indicate that earlier-stage AI companies can still attract capital, though the terms remain opaque.
For founders tracking funding patterns, the week's filings point toward AI applications with clear enterprise buyers. Qualitate sells to investment teams. K Health sells to health systems. Status, with its consumer-facing product, is the outlier, and its smaller round and five-year runway suggest a longer path to proving its model.
Need Help Implementing This?
Whether you're raising a round or tracking competitors' funding activity, understanding SEC filings is essential. Reach out to Logicity's editorial team for deeper dives on startup funding trends and what they mean for your strategy.
Source: AlleyWatch
Manaal Khan
Tech & Innovation Writer
Produced with AI assistance and reviewed by the Logicity editorial team. Learn more in our Editorial Policy.
